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Differences in the Pathways for Metabolism
of Benzene in Rats and Mice Simulated by a
Physiological Model
by Michele A. Medinsky,* Patrick J. Sabourin,* Rogene F.
Henderson,* George Lucier,t and Linda S. Birnbaumt
Studies conducted by the National Toxicology Program on the chronic toxicity ofbenzene indicated that
B6C3F1 mice were more sensitive to the carcinogenic effects ofbenzene than were F344 rats. Aphysiologi-
cal model was developed to describe the uptake and metabolism ofbenzene in rats and mice. Our objective
was to determine ifdifferences in toxic effects could be explained by differences in pathways for benzene
metabolism or by differences intotal uptake ofbenzene. Compartments incorporated into the model included
liver, fat, a poorly perfused tissue group, a richly perfused tissue group, an alveofar or lung compartment
andblood. Metabolism ofbenzene was assumed to take place only in the liver and toproceed byfourmajor
competingpathways. These includedformation ofhydroquinone conjugates (HQC), formationofphenyl con-
jugates (PHC), ring-breakage andformation ofmuconic acid (MUC), andconjugation with glutathione with
subsequentmercapturic acid (PMA) formation. Values forparameters such as alveolarventilation, cardiac
output, organ volumes, blood flow, partition coefficients, and metabolic rate constants were taken from the
literature.
Model simulations confirmed thatduringandafter6-hrinhalation exposuresmicemetabolized morebenzene
on ammole per kilogram body weight basis than did rats. After oral exposure, rats metabolized more ben-
zene than mice atdoses above 50mg/kgbecause ofthe more rapid absorption and exhalation ofbenzene by
mice. Model simulationsforPHCandPMA, generallyconsideredtobe detoxification metabolites, weresimilar
in shape and dose-response to those fortotal metabolism. However, simulations for the metabolites represen-
tative oftheputative toxicationpathways, HQC and MUC, indicated thatafterbothoral andinhalation ex-
posures mice would produce more ofthese metabolites than rats at all concentrations. This was due to the
greater rates ofmetabolism to these metabolites for mice compared to rats. Increased metabolism ofben-
zene through the HQC andMUCpathways in mice is consistent with the observed susceptibility ofthis spe-
cies to benzene toxicity.
Introduction
Benzene is animportant andwidely used industrial sol-
vent (1). Epidemiology studies have shown an increase of
leukemias andaplastic anemia inworkers exposed to ben-
zene (2). To estimate thepotential carcinogenic effects of
benzene, the National Toxicology Program(NTP)orally
exposed F344/N rats and B6C3F1 mice tobenzene in corn
oil for 2 years (3). Mice were identified in these studies
as the more sensitive species. An increased incidence of
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lymphomas, lung tumors, and glandular tumors was
noted.
It isgenerally recognized that metabolism ofbenzene
is necessary for the expression oftoxicity. What is not
known, however, is the ultimate toxic metabolite or com-
bination ofmetabolites. Figure 1 is a simplified scheme
forthe metabolism ofbenzene. The metabolites outlined
in the scheme were based on the work ofSabourin et al.
(4-6) and Bechtold et al. (7) who studied the metabolism
ofbenzene in F344 rats and B6C3F1 mice afteroral orin-
halation exposure. Includedinthis scheme are two puta-
tive toxicmetabolites, benzoquinone andmuconaldehyde.
Thepathwaysfortheformation ofthesereactivemetabo-
lites suggest thatlevels ofthe stablemetabolites, hydro-
quinone conjugates and muconic acid, could be used as
markers for the formation of benzoquinone and
muconaldehyde. For example, a species with a high ca-
pacityforformation ofhydroquinone conjugatesmightbeMEDINSKYETAL.
assumed to produce more benzoquinone compared to a
species with alowcapacityforformation ofhydroquinone
conjugates. The two other pathways in Figure 1 repre-
sent pathways leading to formation of two important
groups ofdetoxification metabolites, thephenylandmer-
capturic acid conjugates.
Toxicokineticmodels canbeusedto offerinsights into
themechanisms thatproduce toxic effects andtoexplain
the differences notedin the toxic effectsbetween species.
Models can also be used for extrapolation. Typical ex-
trapolations include thosefrom animal studies to human
exposures, from a single to continuous exposure, and
from high to low concentrations.
The objectives ofour study were to develop aphysio-
logical model to simulate the metabolism ofbenzene af-
ter oral orinhalation exposure and to compare results of
model simulations conducted for rats and mice. We
wanted to determine if differences in toxic effects seen
inrats and mice couldbeexplainedbydifferences inpath-
ways for metabolism or by differences in total metabo-
lism.
Benzene Physiological Model
Structure
The physiological model constructed to describe the
metabolism ofbenzene, the differential equations driving
the model, and experimental data used to derive model
parameters have been described elsewhere (8,9). This
modelis an adaptionofthatproposedby Ramsey andAn-
derson (10). A diagram ofthe model ispresented in Fig-
ure 2 andtheparametersincorporated into the model to
describe disposition ofbenzeneby rats and mice arepre-
sented in Table 1. As indicated in Table 1, the physiolog-
ical parameters such as cardiac output, alveolar ventila-
tion, blood flow to organs, organ volumes, body weight,
and the chemical parameters such as blood/air and tis-
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FIGURE 1. Scheme for metabolism of benzene. Biochemical rate con-
stants are outlined in Table 1. This scheme for metabolism ofben-
zene takes place in the liver compartment described in Fig. 2. (C])
Represent metabolites ofbenzene that were measured and used in
model simulations; (LI) represent intermediate metabolites that were
not incorporated into the model.
FIGURE 2. Physiological model ofbenzene metabolism. Metabolism of
benzene waspresumed totakeplace in thelivercompartment. Path-
ways for benzene metabolism incorporated into the model are shown
in Fig. 1.
sue/blood partition coefficients for benzene were taken
from the literature. Values for gastrointestinal-liver
transport andthemetabolic rate constants were adjusted
untilresultsfrommodel simulations comparedfavorably
to data determined by Sabourin et al. (5,9). Methods for
these determinations have been describedpreviously(8).
In this model benzene can be inhaled or ingested. In-
haledbenzene willbe absorbed into the blood in propor-
tion to the benzene blood/air partition coefficient pre-
sented in Table 1. Once in the blood, benzene will be
transported to other organs in proportion to blood flow
to that organ (or group of tissues) and the benzene tis-
sue/blood partition coefficient. Ingested benzene is as-
sumed to be translocated from the gastrointestinal tract
to the liver by a first order process.
Tissue compartments included in the model were a)
liver, the only organwhere metabolism ofbenzene takes
place; b)group ofpoorlyperfused tissues includingmus-
cle and skin, c) agroup ofrichly perfused tissues includ-
ingbonemarrow, kidney, andintestines; and d)afat com-
partment. The poorly perfused tissues are important
because of the large body mass they represent, the
rapidly perfused tissues because ofthe large blood flow
to these tissues, and the fat compartment because ofits
large partition coefficient. Large tissue mass, high blood
flow, and increased solubility will each result in signifi-
cant amounts ofbenzene being distributed to that com-
partment. However, the kinetics of distribution will be
different for each compartment.
Any benzene that does not partition into any of the
above compartments willreturnto thelungsthroughthe
venous circulation. Dependingon the alveolar concentra-
tion ofbenzene, benzene in the venous blood can parti-
tion into the alveolar space and be exhaled. During a
prolonged inhalation exposure, an equilibrium canbe es-
tablished between the alveolar concentration and venous
concentrations ofbenzene. However, thereare situations
in which there will be a net efflux ofbenzene from the
blood into the alveolar space, such as after an oral ex-
posure orafterthe end ofaninhalation exposure. This is
because the concentration of benzene in the alveolar
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Table 1. Parameters used in the physiological simulation model for benzene metabolism in F344 rats and B6C3F, mice.
Value
Parameter Rats Mice
Physiological
Aveolar ventilation, L/hr kga 32.4 55.3
Cardiac output, L/hr
- kgb 19.4 34.8
Gastrointestinal transfer, fraction/hr 0.25 3.0
Body weight, kg 0.288 0.030
Blood flow (fraction of cardiac output)b
To liver 0.25 0.25
To fat 0.09 0.09
To poorly perfused tissuesc 0.15 0.15
To richly perfused tissuesd 0.51 0.51
Organ volumes (fraction of body weight)'
Blood 0.056 0.056
Liver 0.03 0.03
Fat 0.11 0.11
Poorly perfused tissues 0.74 0.74
Richly perfused tissues 0.06 0.06
Chemical
Molecular weight, g/mole 78.2 78.2
Partition coefficientsf
Liver/blood 1.0 1.0
Fat/blood 28.0 28.0
Poorly perfused tissues/blood 0.6 0.6
Richly perfused/blood 1.0 1.0
Blood/air 18.0 18.0
Biochemical parametersg
Vmax,, mole/hr* kg 122 200
Kin, Jmole/L 40 1.0
Vmax, phc, jimole/hr kg 174 333
Ki, phc, Amole/L 5 3.0
Vmax pmc, ,Amole/hr * kg 104 90
Ki, pmc, umole/L 15 4.0
V.ax, hqc, Hmole/hg * kg 1.7 27
Ki, hqc, Mmole/L 0.5 0.1
Vmax, mucI jAmole/hr kg 3.5 12
Km, muc,Mmole/L 0.5 0.1
aExperimentally determined (9).
bData from Ramsey and Andersen (10).
cIncludes muscle, skin and bone.
dIncludes kidneys, brain, heart, spleen, intestines, bone marrow, etc.
'Data from Dutcher et al. (11) and Birnbaum et al. (12).
'Data from Thomas (13).
gRefer to Fig. 1
space will be lower than the concentration ofbenzene in
the blood for both oral and inhalation exposure.
In the model, metabolism ofbenzene occurs onlyin the
liver. Michaelis-Menten kinetics are used to model the
formation ofthe benzene metabolites outlined in Figure
1. Both the total amount ofbenzene metabolized and the
total amounts of the individual metabolites formed are
tracked in this model. Initially benzene ismetabolized to
benzene oxide, which is further metabolized by one of
four pathways. The first metabolite is formed by rear-
rangement of the benzene oxide to phenol followed by
conjugation of phenol to phenyl sulfate or phenyl
glucuronide. Thus, forthepurposes ofmodelsimulations,
the total amounts of phenyl sulfate and phenyl
glucuronide were combined andexpressed as totalphenyl
conjugates. A secondpathway for benzene oxide metab-
olism consisted of reaction with glutathione and subse-
quent modification of the mercapturic acids. This path-
waywasrepresentedbycombining the total amounts of
prephenylmercapturic acid andphenylmercapturic acid.
The thirdpathwayforbenzene metabolism involved rear-
rangement of benzene oxide to phenol, oxidation to
hydroquinone, and conjugation to hydroquinone
glucuronide or sulfate. For this pathway total amounts
of hydroquinone glucuronide and hydroquinone sulfate
formed were combined. The fourthpathway was metab-
olism of benzene oxide to muconic acid presumably
through a muconaldehyde intermediate. Although ben-
zene could be metabolized to other metabolites such as
catechol or trihydroxybenzene, only very low levels of
these metabolites were found in animal studies (4-6) and
thus pathways for formation of these metabolites were
not included in our model.
Benzene Physiological Model
Simulations
Using the parameters in Table 1 and the model struc-
ture described in Figure 2(8), we conducted simulations
ofuptake ofbenzene by rats and mice over a range oforal
45MEDINSKYETAL.
or inhalation exposures. The total amount of benzene
metabolized aswellas theformationofindividualmetabo-
lites was simulated over a48-hrperiod. Results ofmodel
simulations for total benzene metabolized after exposure
of rats and mice to a range of concentrations are pre-
sentedin Figure 3. The oral simulationsrepresentmetab-
olismofbenzenefollowing asingle bolusgavagewithvar-
ious doses of benzene. The inhalation exposures
represent metabolism ofbenzene during and after a sin-
gle 6-hrinhalation exposure. Tofacilitate comparisons be-
tween rats andmice, model simulations were expressed
asMmolebenzene metabolized perkilogrambodyweight.
Thus, all comparisons described are in terms ofrelative
amounts.
Simulations demonstrated that for mice, formation of
more benzene metabolites could be achieved by inhala-
tion exposure over a6-hrperiod as compared to oral ex-
posures. For rats, similar amounts of benzene were
metabolized afterinhalation exposure ororal administra-
tion. It is apparent that for any given inhaled benzene
concentration, mice will metabolize morebenzene as com-
paredtorats(Fig. 3). Totalmetabolismofbenzene inrats
and mice is similar for oral exposures up to 50 mg ben-
zene/kg. Above that, rats metabolize more benzene than
do mice.
Similar pictures are presented for the phenyl con-
jugates as indicated in Figure 4 and the phenyl mercap-
turic acids in Figure 5. Model simulations indicated that
mice produce more ofthese metabolites after inhalation
exposure comparedtorats onaper kilogrambodyweight
basis. Except forvery low oral doses, rats produce more
ofthese metabolites as compared to mice when expressed
on a per kilogram body weight basis.
Inlooking atthehydroquinone conjugates (Fig. 6)and
muconic acid(Fig. 7), markers for toxic metabolites, the
simulations are very different than those seen for the
detoxification metabolites orfortotal metabolism. In the
case ofthe hydroquinone metabolites, miceproducedfar
greater amounts ofthese metabolites after all inhalation
or oral exposures compared to rats. For example,
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FIGURE 3. Total metabolism ofbenzene in rats and mice compared af-
ter oral administration (0) or a single 6-hr inhalation exposure (1).
Lines represent results of model simulations for rats and mice.
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FIGURE 4. Phenyl conjugates excreted by rats and mice compared af-
ter oral administration (0) or a single 6-hr inhalation exposure (1).
Lines represent results of model simulations for rats and mice.
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FIGURE 5. Phenyl mercapturic acids excreted by rats and mice com-
pared after oral administration (0) or a single 6-hr inhalation exposure
(1). Lines represent results of model simulations for rats and mice.
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FIGURE 6. Hydroquinone conjugates excreted by rats and mice com-
pared after oral administration (0) or a single 6-hr inhalation exposure
(I). Lines represent results of model simulations for rats and mice.
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FIGURE 7. Muconic acid excreted by rats and mice compared after oral
administration (0) or a single 6-hr inhalation exposure (1). Lines
represent results of model simulations for rats and mice.
amounts ofhydroquinone conjugates produced by rats at
300mg/kgoral exposures were similartolevelsproduced
by mice after only 12 mg/kg exposure. Since hydroqui-
none is considered to be amarker forbenzoquinone, one
oftheputative toxicmetabolites, these model simulations
are consistent with the observed differences in toxicity
between rats and mice orally exposed to benzene.
Larger amounts ofmuconic acid, amarkerforthe puta-
tive toxic metabolite muconaldehyde, were'also seen in
mice afteroral orinhalation exposure compared to rats.
After oral administration these results are not as dra-
matic as those seen for hydroquinone. Considering that
after oral exposure rats metabolize more total benzene
compared to mice when expressed on a *mole per kilo-
gram body weight basis, the larger amounts ofmuconic
acidformice indicated that agreater portion ofbenzene
metabolism isthrough the muconic acidpathway in mice.
Discussion and Extrapolation
The major results ofmodel simulations were that me-
tabolism to hydroquine conjugates andmuconic acid rep-
resent significant metabolic pathways in mice. In con-
trast, rats metabolize benzene primarily to the phenyl
conjugates and the phenyl mercapturic acids. This
differential metabolism of benzene by rats and mice is
consistent with the increased susceptibility to the toxic
effects ofbenzene exhibitedby mice compared to rats as
noted in chronic oral toxicity studies conducted by the
National Toxicology Program(3). Increasedformation of
hydroquinone conjugates andmuconic acid maybe anin-
dication that increased concentrations of either benzo-
quinone, unconjugated hydroquinone, muconaldehyde, or
a combination ofthese metabolites are present inthe tar-
get tissues of mice compared to rats.
Currently, the model structure presented here does not
enable us to predict the concentration of these uncon-
jugated and reactive metabolites in tissues such as the
target cells ofthe bone marrow. We are simulating only
the formation ofthe end products ofbenzene metabolism,
the water soluble urinary metabolites. As such we have
assumed for purposes ofsimplification that metabolism
ofbenzene occurs only in the liver. This may ormay not
be true. It is likely that the target organs such as bone
marrow are capable ofmetabolism ofbenzene, phenol, or
hydroquinone. Thus, distribution ofthese compounds to
tissues such as bone marrow is an important process to
consider in the formation ofphysiological models in the
future.
One ofthe mostusefulfeatures ofaphysiological model
is insight into the factors that are critical in the uptake
andmetabolism ofa chemical. For example, the rate con-
stants for metabolism of benzene by rats and mice are
very different. As indicated in Table 1, the maximum
rates formetabolism ofbenzene oxide to the hydroquin-
one conjugates andmuconic acid arehigherformice com-
pared to rats. These highermaximum ratesresult infor-
mation ofmore ofthese metabolites.
The rate constants for benzene metabolism in Table 1
canbe divided into two groups. The first group includes
metabolites with a small apparent K., hydroquinone, and
muconicacid. The secondgroup includesmetabolites with
alargeapparentKi, thephenyl conjugates, andmercap-
turic acids. Km is definedin Michaelis-Mentenkinetics as
the concentration ofthe substrate at which the reaction
velocity is half-maximal. In addition, the detoxification
metabolites have larger Vmax than do the toxification
metabolites. This suggeststhatmetabolismto hydroquin-
one andmuconicacid arelow-capacity, high-affinity path-
ways while metabolism tophenyl conjugates andmercap-
turic acids follows a higher capacity, lower affinity
enzyme system.
The implication of the relationshlip between these
parameters can be seen in Figures 8A and 8B. These
figures compare total metabolism andtheformation ofin-
dividual metabolitesby mice as a function of6-hr inhala-
tion exposure to various concentrations ofbenzene. Above
approximately 75 ppm thephenyl conjugates are the pre-
dominant metabolites produced. Equal amounts of the
hydroquinone conjugates and the mercapturic acids are
formed. Muconic acid is produced in the smallest quan-
tity. However, for concentrations below 200 ppm, the ef-
fect ofthe differences in the Km values ofthe pathways
is apparent (Figure 8B). At concentrations below approx-
imately 35 ppm, the hydroquinone conjugates are
produced in the highest quantity. Above that concentra-
tion theproduction ofthephenyl conjugates exceeds that
ofthe hydroquinone conjugates, which increases in a non-
linear manner. Similarly, at concentrations below approx-
imately 75 ppm, muconic acid is produced in greater
amounts than the mercapturic acids. Above 75 ppm, for-
mation ofmercapturic acids exceeds that ofmuconic acid.
Figure 8B suggests that theproportion oftotal metab-
olism due to individual metabolites athigh concentrations
(e.g., above 200 ppm) is not predictive ofmetabolism at
lower concentrations. Since the putative toxic metabo-
lites are preferentially produced at low concentrations,
this means thatlinearextrapolation ofmetaboliteprofiles
from high concentrations to low concentrations will un-
derestimate the contribution of the putative toxic
metabolites tototalmetabolism. Iftoxicityisproportional
to the flux of benzene through the putative toxication
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FIGURE8. Comparison ofbenzene metabolites produced by mice after
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total metabolism orindividual groups for concentrations up to 1000
ppm benzene (A) or 200 ppm benzene (B).
pathways ofmuconaldehyde andbenzoquinone formation,
and if there is no threshold in the concentration of
metabolites required to elicit a toxic response, then lin-
ear extrapolation oftoxic effects obtained at high doses
may underestimate the risk at low exposures.
The physiological model can also be used to gain in-
sights into differences in the uptake of a chemical as
related to different exposure routes. Forexample, after
oralexposureratsmetabolize more benzenethandomice,
yet afterinhalation exposure mice metabolize more ben-
zene at allexposure concentrations (Fig. 1). In both cases
the identical Vmax andKmfor overall metabolism ofben-
zene are used for inhalation or oral exposure, although
different metabolic parameters are used for rats and
mice. Inthe model simulations, the differences inuptake
between rats andmice were due tothe differencesinthe
gastrointestinal translocation rate constants for these
species (Table 1). This is demonstrated in Figure 9A in
which the total metabolism ofbenzene by mice is simu-
lated following oral exposure to 50 mg benzene/kg. In
these simulations, thegastrointestinal-livertranslocation
rate constantwasvariedfrom4hr-' to0.5hr-'. The simu-
lations demonstrate thatdecreasingthe rate constantfor
gastrointestinal transport ofbenzene increasedthe total
time over which benzene was transported to the liver.
This slower delivery ofthe sametotal amount ofbenzene
ultimately results in more benzene being metabolized.
Anybenzene that is not metabolized will be exhaled (9).
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FIGURE9. Effect ofvariations in the gastrointestinal transferrate con-
stant(Ka) oncumulative totalmetabolism(A)ofbenzeneby mice af-
ter oral exposure to 50 mgbenzene/kg body weight or on the exha-
lation ofunmetabolized benzene (B).
Figure 9B demonstrates the effect of alterations in the
gastrointestinal translocation rate constant on the
amount of benzene exhaled. As the rate constant in-
creased, the total amount ofbenzene exhaled increased.
Thus, benzene that is not metabolized by the liver can
partition into the blood. As thisbloodpassesthroughthe
lungs the benzene will be exhaled proportional to the
blood/airpartition coefficient. Model simulations are con-
sistent with the observations of Sabourin et al. (9) who
demonstrated that with increasing oral exposure an in-
creasingfraction ofthe benzene was exhaled unmetabo-
lized.
In contrast, the uptake ormetabolism ofbenzene after
inhalation exposure istheresultofthe differencesin Vm.
and Km between species (Fig. 10). Although the rate of
alveolar ventilation of mice is approximately twice that
ofrats, suggestingthat themicewill inhale morebenzene
thanwill rats; theywill also exhale morebenzene. Metab-
olism ofbenzene is related to the concentrations in the
arterial blood going to the liver. For any given air con-
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Lines are results ofmodel simulations ofcumulative total metabo-
lismduringandaftera6-hrexposureto300ppmbenzene. Parameters
used in the simulations are indicated in Table 1.
centration, the concentration ofbenzene in the blood is
directly related to the blood:air partition coefficient,
which is identical for rats and mice. Thus, as demon-
strated inFigure 10, simulation ofaninhalation exposure
withratventilation parameters andmousenietabolicrate
constants results in a total amount ofbenzene metabo-
lized that is similar to results with both mouse ventila-
tion andmetabolismparameters. Simulations withmouse
ventilation-rat metabolism andrat ventilation-rat metab-
olism produce comparable results.
In summary, aphysiological modelhasbeenusedto de-
scribe the uptake and metabolism of benzene. Model
simulations as well as the experimental data ofother in-
vestigators (4-7,9) indicate that metabolism ofbenzene
inmicefavorsthepathwaysleadingtotheputativetoxic
metabolites, benzoquinone and muconaldehyde, whereas
metabolism ofbenzene inrats isprimarily through detox-
ification pathways. These predictions are consistentwith
the observed increased sensitivity ofmice to the toxic ef-
fects of benzene compared to rats.
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